Stocks and Investing Stocks and Investing
Thu, April 4, 2019
Wed, April 3, 2019
Tue, April 2, 2019

Gena Wang Maintained (BCRX) at Hold with Increased Target to $8 on, Apr 2nd, 2019


Published on 2024-10-26 12:52:36 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold with Increased Target from $6 to $8 on, Apr 2nd, 2019.

Gena, nor any peers, have made any analyst calls on BCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources